Clinical Features of ICU Admitted and Intubated Novel Corona Virus-infected Patients in Iran

authors:

avatar Ramin Hamidi Farahani ORCID 1 , avatar Mohammad Gholami ORCID 2 , avatar Ebrahim Hazrati ORCID 3 , * , avatar Negin Hosseini Rouzbahani 4 , avatar Zia Hejripour 5 , avatar Saeed Soleiman-Meigooni ORCID 2 , 6 , avatar Maryam Dadmanesh 1 , avatar Mahtab Noorifard 6 , avatar Jalal Kargar 7 , avatar Farhad Motavalli 8 , avatar Reza Laripour 9 , avatar Abbas Nourmohammadi 10 , avatar Sanaz Zargar ORCID 11

Department of Infectious Diseases, School Of Medicine, Aja University of Medical Sciences, Tehran, Iran
Department of Microbiology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran
Department of Anesthesiology and Critical Care, Aja University of Medical Sciences, Tehran, Iran
Department of Immunology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran
Department of Emergency Medicine, Aja University of Medical Sciences, Tehran, Iran
Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran
Department of Radiology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran
Department of Biotechnology, Aja University of Medical Sciences, Tehran, Iran
Center for Educational Reaearch in Medical Sciences, Aja University of Medical Sciences, Tehran, Iran
Aerospace and Diving Medicine Faculty, Aja University of Medical Sciences, Tehran, Iran
Department of Health Management and Economics, School of Medicine, Aja University of Medical Sciences, Tehran, Iran

how to cite: Hamidi Farahani R, Gholami M, Hazrati E, Hosseini Rouzbahani N, Hejripour Z, et al. Clinical Features of ICU Admitted and Intubated Novel Corona Virus-infected Patients in Iran. Arch Clin Infect Dis. 2020;15(2):e103295. https://doi.org/10.5812/archcid.103295.

Abstract

Background:

Recently, a novel coronavirus was reported from Wuhan, Hubei Province, China. The novel coronavirus infection was spread from China to other countries, including Iran.

Objectives:

We report the clinical characteristics, laboratory findings, and chest exams of infected patients.

Methods:

All patients suspected to the novel coronavirus were hospitalized in a special airborne protection room. We collected and analyzed the characteristics of confirmed patients by data extraction from electronic medical records.

Results:

The Computerized Tomography (CT) scan and radiography results showed ground glass in the lung of patients, and real-time PCR confirmed the infection. The myocardial and liver function tests showed abnormalities in infected patients.

Conclusions:

Most patients admitted to the Intensive Care Unit (ICU) showed respiratory problems, and their infection was confirmed by virological tests and chest images. The main reason for the patient’s death was the signs of acute heart failure, such as hypotension and cardiac arrhythmia.

1. Background

Most coronaviruses cause mild infections in humans (1). In the past decade, two coronaviruses belonging to betacoronaviruses, including Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), infected more than 10,000 people all around the world, with a mortality rate of 10% and 37% for SARS and MERS, respectively (2, 3). Recently, in December 2019, patients with clinical presentations of viral pneumonia were reported from Wuhan, Hubei, China (4, 5). The sequencing results of patients’ samples revealed that Wuhan patients were infected with a novel coronavirus (COVID-2019). Several reports all around the world, including Japan, South Korea, USA, Italy, and Germany, confirmed the prevalence of the novel coronavirus (2019-nCoV) (6, 7). Based on the WHO, pneumonia of COVID-19 is highly infectious, and this outbreak is one of the most important public health problems. It has distributed broadly due to human-to-human transmission in countries that have challenges with this agent (4, 5).

2. Objectives

In this study, we report and describe novel coronavirus-infected patients with pneumonia whose specimens were confirmed in the Pasture Institute of Iran. We also describe the clinical features of patients infected with the novel coronavirus.

3. Methods

3.1. Patient Isolation

Following the emergence of COVID-2019 in Iran, patients with pneumonia signs were considered to be infected with COVID-19. For the time being, 10 patients suspected to COVID-19 with cough and fever more than 38ºC, were transferred to an isolated region in ICU. furthermore after government alert, a rapid response team contain physician, virologist, and nursing was formed. The diagnosis of COVID-19 was according to the clinical characteristics, chest exam, laboratory findings, and virologic tests. The patients suspected to COVID-19 were isolated in a special airborne protection agent room.

3.2. Ethics Statement

This study was approved by the Infectious Disease Ethical Review Board.

3.3. Data Gathering

We investigated the clinical characteristics, chest imaging, liver function tests, and laboratory findings of patients suspected to COVID-19 (8, 9). The data were extracted from electronic medical records of infected patients.

4. Results

In this study, 10 out of 22 patients with positive clinical and laboratory results of COVID-19 infection were hospitalized and intubated in a special airborne protection agent room. The median age of the patients was 50 years. The demographic characteristics of the infected patients are summarized in Table 1.

Table 1.

Demographic Characteristics of Infected and Intubated Patients with COVID-19

VariablesPatients (N = 10)
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10
Age45566542554056604043
SexFemaleMaleMaleMaleMaleFemaleMaleMaleFemaleMale
SmokingNoYesYesYesYesNoYesYesNoYes
DiabetesNoYesYesNoNoNoYesYesNoNo
HypertensionYesYesYesNoYesYesYesYesNoNo
Clinical symptoms
Fever403838.538.4394038.5403737
DyspneaYesYesYesYesYesYesYesYesYesYes
PhenomenaYesYesYesYesYesYesYesYesYesYes
FatigueYesYesYesYesYesYesYesYesYesYes
HeadacheYesYesYesYesYesYesYesYesYesYes
CoughYesYesYesYesYesYesYesYesYesYes
HaemoptysisNoNoNoYesNoNoNoYesNoNo
Bradycardia +YesYesYesYesYesYesYesNoNo

4.1. Laboratory Characteristics

All hospitalized patients showed leucopenia. The cardiac-related enzymes were higher in patients admitted to the ICU. The liver function test LFT results showed variations in infected patients. The laboratory findings are summarized in Table 2.

Table 2.

Clinical Characteristics of Infected and Intubated Patients with COVID-19

VariablesPatients (N = 10)
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10
WBC (× 103/mlcl)13.95.712.7520.116.25.569.74.73.6
RBC (× 106/mlcl)4.843.463.913.323.843.613.984.614.514.45
ALT (U/L)11605012313012530401723
AST (U/L)101008817816717750793545
Hb11.81011.5811.811.37.212.212.911.110
HCT39.731.833.834.634.22537.438.5--
Platelet231-343.0155166158314244200151
Lymphocyte (%)17168.807.7151026123832
Neutrophils (%)607986.9388808770855964
CRP (mg/L)31224522302323`121314
LDH (U/L)45160555545617431516666-520-
CPK (U/L_38149140960138392200251201546
BUN502547131563822324018
Ck-MB50256089757720162416
Alk.ph237115244250155177180133113

4.2. Chest Images

Chest CT images revealed the presence of abnormalities in all admitted patients. The CT scan and radiographic images of seven dead patients revealed bilateral multilobar ground-glass opacity, consolidation, and ground-glass opacity with interlobular septal thickening (crazy-paving) in the peripheral distribution in infected patients. The results are shown in Figure 1.

Chest radiography and CT scan results. CT scan shows bilateral multifocal ground-glass/crazy-paving and consolidation in peripheral distribution. AP chest radiographs show multifocal patchy consolidation in bilateral lungs.
Chest radiography and CT scan results. CT scan shows bilateral multifocal ground-glass/crazy-paving and consolidation in peripheral distribution. AP chest radiographs show multifocal patchy consolidation in bilateral lungs.

5. Discussion

In early 2020, the outbreak of novel coronavirus (COVID-19) occurred, and it spread from China to other countries. Many viruses can cause respiratory infections, and there is evidence that viruses in the same family have similar pathogenesis (5).

We evaluated the clinical and laboratory characteristics of 22 patients that were ICU-admitted and confirmed cases of COVID-19 infection. Ten (45.4%) patients were intubated. In this study, we reported COVID-19 diagnosis in patients hospitalized in Tehran, Iran. The average age of patients was 50 years, and their disease was confirmed based on and CT scans, radiographic images, and real-time PCR.

Seven of 10 patients in this study died; they had diffused ground-glass opacities in radiographic images. Radiologic findings mostly indicated bilateral multilobar ground-glass opacity and consolidation with interlobular septal thickening (crazy-paving) in peripheral distribution (10-13). Most patients presenting with severe respiratory symptoms and respiratory failure were hospitalized in the ICU. Two of seven intubated patients died because of hemoptysis and respiratory failure. The rest of the patients (five of seven) died with the signs of acute heart failure, such as hypotension, cardiac arrhythmias, and cardiogenic shock. The liver and cardiac-related enzymes of all patients were elevated. Most patients had lymphopenia without leukocytosis (14). Our data showed that COVID-19 infection was more important in older people, and the more severity of infection in these patients was probably due to their weaker immune system or coexisting diseases (15, 16). Seven patients showed degrees of abnormality in their liver function, and their ALT and AST enzymes were above normal. Most abnormal myocardial enzymes revealed the elevation of CK-MB and LDH enzymes. Delayed referral and diagnosis may be the other important causes of mortality in these patients (14).

5.1. Conclusion

Most patients infected with the novel coronavirus were admitted to intensive care units because of respiratory problems, but the causes of death of patients, except for two patients, were related to sudden cardiac arrest and delayed referral and diagnosis. It is very important to diagnose high-risk patients in the early stage of infection.

Acknowledgements

References

  • 1.

    Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. J Trends in microbiology. 2016;24(6):490-502.

  • 2.

    Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt H, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. J New England journal of medicine. 2003;348(20):1967-76.

  • 3.

    Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chan KH, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. The Lancet. 2003;362(9393):1353-8.

  • 4.

    Na Z, Dingyu Z, Wenling W. A Novel Coronavirus from Patients with Pneumonia in China, 2019. J N Engl J Med. 2020.

  • 5.

    Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. J The Lancet. 2020.

  • 6.

    Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. J The Lancet. 2020;395(10223):470-3.

  • 7.

    Haynes B, Messonnier NE, Cetron MS. First travel-related case of 2019 novel coronavirus detected in United States: press release, Tuesday, January 21, 2020. 2020.

  • 8.

    World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (‎2019-nCoV)‎infection is suspected: interim guidance, 28 January 2020. World Health Organization; 2020.

  • 9.

    Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. J Eurosurveillance. 2020;25(3).

  • 10.

    Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). J Radiology. 2020:200230.

  • 11.

    Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. J The Lancet. 2020.

  • 12.

    Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan Y, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). J Military Medical Research. 2020;7(1):4.

  • 13.

    Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. J New England Journal of Medicine. 2020.

  • 14.

    Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. J The Lancet. 2020;395(10223):507-13.

  • 15.

    Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. J International Journal of Infectious Diseases. 2016;49:129-33.

  • 16.

    Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. J Clinical Microbiology Infection. 2015;21:S27-32.